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Purpose: To screen the visual system homebox 1 (VSX1) gene in Saudi Arabian keratoconus patients.
Methods: We sequenced the entire coding region, exon-intron boundaries in clinically confirmed keratoconus patients
(n=55) and 50 ethnically matched healthy controls. All cases and controls were unrelated.
Results: Sequencing VSX1 revealed the presence of five nucleotide changes, 3 of which were non-coding (g.8326 G>A,
g.10945 G>T, and g.11059 A>C) and 2 were synonymous-coding sequence changes (g.5053 G>T and g.8222 A>G). All
five sequence changes were benign polymorphisms with no apparent clinical significance.
Conclusions: In our keratoconus cohort, no pathogenic VSX1 mutation(s) were identified.
Keratoconus  (KTCN;  OMIM  148300)  is  a  non-
inflammatory thinning and anterior protrusion of the cornea
that results in steepening and distortion of the cornea, altered
refractive powers and altered visual acuity. In more advanced
cases,  corneal  scarring  from  corneal  edema  and
decompensation further reduces visual acuity. Symptoms are
highly variable and depend on the stage of progression of the
disorder  [1,2].  The  prevalence  of  keratoconus  has  been
reported to vary in different studies, from 8.8 to 54.4 per
100,000 [3,4], the variation is in part due to the different
diagnostic criteria used. The incidence of keratoconus ranges
between 1/500 to 1/2,000 individuals throughout the world
[5].  The  disease  occurs  with  no  ethnic  or  gender
preponderance and causes significant visual impairment [2,
5,6].  Keratoconus  should  be  divided  into  three  broad
categories:  i)  keratoconus  associated  with  rare  genetic
disorders (such as Down syndrome, nail-patella syndrome,
neurofibromatosis,  etc);  ii)  keratoconus  in  the  setting  of
commonly  reported  associations  (contact  lens  wear,  eye
rubbing,  atopy,  Leber  congenital  amaurosis,  mitral  valve
prolapsed  and  positive  family  history)  and  iii)  isolated
keratoconus with no associations. Most cases of keratoconus
are  sporadic  but  some  (5%–10%)  have  a  positive  family
history [6,7]. In such cases both autosomal recessive and
dominant patterns of inheritance have been reported [8-11].
There are several chromosomal loci and genes reported to be
associated  with  keratoconus  [6,11].  some  of  which  were
eventually  excluded  [6,12],  while  others  showed  no
confirmed association with the disease [13,14]. This is not the
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case for the visual system homebox 1 (VSX1) gene where
mutations associated with keratoconus cases have been found
in different studies [15-18], although other studies which did
not find VSX1 mutations in cohorts of keratoconus patients
from  various  populations  [19,20].  This  indicates  that
keratoconus is a complex condition of multi-factorial etiology
and that mutations in VSX1 are not responsible for all cases of
keratoconus. To our knowledge, this is the first time VSX1 was
screened for mutations in the Saudi keratconus patients.
METHODS
Patients and controls: The study adheres to the tenets of the
Declaration  of  Helsinki,  and  all  participants  signed  an
informed consent. The study was approved by the College of
Medicine  (King  Saud  University,  Riyadh,  Saudi  Arabia)
ethical committee (proposal number # 09–659). All study
subjects  were  self  identified  of  Saudi  Arabian  ethnicity.
Family names were all present in the database of Arab families
of Saudi Arabian origin. In this study we screened 55 unrelated
Saudi  Keratoconus  patients  (each  patient  represents  one
family)  and  50  ethnically  matched  unrelated  controls  for
mutations  in  the  VSX1  gene.  Patients  were  selected  from
the  anterior  segment  clinic  at  King  Abdulaziz  University
Hospital  after  examination.  Patients  were  diagnosed  with
keratoconus  if  the  Schimpff-flow  based  elevation  map
showed posterior corneal elevation within the central 5 mm ≥
+20 µm, inferior-superior dioptric asymmetry (I-S value) >1.2
diopters (D) and the steepest keratometrey >47 D. Patients
were  considered  as  sporadic  cases  after  examining  the
immediate  family  members  and  identifying  the  patient  as
isolated case of keratoconus. Exclusion criteria was based on
presence  of  post-  laser-assisted  in  situ  keratomileusis
(LASIK) ectasia and refusal to participate.
Controls were recruited from the general ophthalmology
clinic and had no ocular disease(s) or previous ophthalmic
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667surgeries.  Their  slit  lamp  exam  showed  clear  cornea  and
their Schimpff-flow based elevation map were within normal
limits.
All  Keratoconus  cases  secondary  to  causes  such  as
trauma,  surgery,  Ehlers  Danlos  syndrome,  Osteogenesis
Imperfecta and pellucid marginal degeneration were excluded
from the study.
DNA  analysis:  Five  milliliters  of  peripheral  blood  were
collected in EDTA tubes from all participating individuals.
DNA was extracted using the illustra blood genomicPrep Mini
Spin Kit from GE Healthcare (Buckinhamshire, UK), and
stored at –20 °C in aliquots until required. PCR amplification
of the VSX1 coding region were performed using the primers
detailed in Table 1. Successfully amplified fragments were
sequenced  in  both  directions  using  the  M13  forward  and
reverse  primers  and  the  BigDye  terminator  v3.1  cycle
sequencing  kit  (Applied  Biosystems,  Foster  city,  CA).
Fragments were then run on the 3130xl Genetic Analyzer
(Applied Biosystems) according to the manufacturer protocol.
All  sequenced  fragments  were  analyzed  using  SeqScape
software  v2.6  (Applied  Biosystems)  and  compared  to  the
VSX1 reference sequence (GenBank NG_008101).
RESULTS
Fifty-five unrelated Keratoconus patients (Table 2) and 50
unrelated controls were recruited into this study. Of the 55
Keratoconus patients there were 24 males and 31 females with
a mean age of 28.9 (SD 7.7). Of the 50 controls there were 19
males  and  31  females  with  a  mean  age  of  60  (SD  17).
Examining the family pedigrees in the keratoconus patients
indicated that the mode of inheritance was sporadic in 56.4%
of  cases,  34.6%  were  autosomal  recessive;  5.4%  were
autosomal dominant, and 3.6% of cases were indeterminable
(Table 2). The full coding region, exon-intron boundaries and
the 5′UTR and 3′UTR of VSX1 was sequenced in all subjects.
We detected five nucleotide changes in both patients and
controls  (Table  3).  Two  were  previously  reported
(rs8123716 and rs12480307; and three are novel; Table 3).
Three of the sequence changes g.5053 G>T, g.8326 G>A, and
g.11059 A>C were heterozygous and two were homozygous
(g.8222  A>G  and  g.10945  G>T).  None  of  the  sequence
changes detected were pathogenic. Two (g.5053 G>T and g.
8222 A>G) were synonymous coding, one intronic (g.8326
G>A), and two (g.10945 G>T and g.11059 A>C) in the 3′
UTR region.
DISCUSSION
We detected five nucleotide changes in both the patients and
control groups-none of which were pathogenic. Similar results
have been published recently [19]. The lack of pathogenic
sequence  changes  in  VSX1  in  our  keratoconus  cohort,
indicates  that  VSX1  mutations  are  not  responsible  for
keratoconus cases in this population. VSX1 is amemeber of
the  Vsx1  group  of  vertebrate  paired-like  homeodomian
transcripition  factors.  It  has  been  localized  to  the  human
chromosome 20p11-q11. VSX1 is considered important in
ocular  development  and  is  particularly  involved  in  the
developing cornea. Expression in human was demonstrated in
embryonic craniofacial, adult cornea and adult retinal cDNA
libraries [21]. VSX1 mRNA has been found in the outer tier of
the inner nuclear layer of the human retina and the cornea
[22].  Thus  far,  mutations  reported  in  this  gene  such  as
p.H244R,  p.G160D,  p.D144E,  p.P247R,  p.L159M,  and
p.R166W have been reported in various ethnic groups, but a
definite pathogenic role has not been established [23]. VSX1
mutations are also associated with posterior polymorphous
dystrophy [24]. For these aforementioned reasons, the direct
link of VSX1 with keratoconus is controversial. This suggest
TABLE 1. PRIMER SEQUENCES, PCR ANNEALING TEMPERATURE, AND AMPLICON SIZE FOR VSX1 PCR AMPLIFICATION.
Exon Primer sequence Annealing temperature
(°C)
VSX1–1F TGTAAAACGACGGCCAGTCAGCTGATTGGAGCCCTTC 60
VSX1–1R CAGGAAACAGCTATGACCGGGGCGATGGTCTGTGAC  
VSX1–2F TGTAAAACGACGGCCAGTCCCAAGAGGTTCATAACTTCAA 60
VSX1–2R CAGGAAACAGCTATGACCTATCATGCCGGGCCATAAAT  
VSX1–3aF TGTAAAACGACGGCCAGTCTGGACAGCAGAGGAAGCA 60
VSX1–3aR CAGGAAACAGCTATGACCTTGGCTATAGAGAAGGGACTGC  
VSX1–3bF TGTAAAACGACGGCCAGTTGGACAGCAGAGGAAGCAG 60
VSX1–3bR CAGGAAACAGCTATGACCTCAGGGGCAGATAATATACTCCA  
VSX1–4F TGTAAAACGACGGCCAGTGCCCCTCTTCACTGTCTCTTC 60
VSX1–4R CAGGAAACAGCTATGACCTTGCTTTGCTTTGGAAATGG  
VSX1–5aF TGTAAAACGACGGCCAGTTGGGATTTAGAGAACAATAAGAAGG 58
VSX1–5aR CAGGAAACAGCTATGACCCAGTGAAATCATTTTTGAACTTCG  
VSX1–5bF TGTAAAACGACGGCCAGTCAGATGAGTGACCTAGGGAAAA 57
VSX1–5bR CAGGAAACAGCTATGACCTGTCACATGTCCCCAGATTG  
F: Forward; R: Reverse; Bold sequences are those of the M13.
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ethat other loci, such as 13q32 [25], may be involved in the
pathogenesis of keratoconus.
In our patient group, we noticed that females were more
affected than males. In the literature, it is unclear whether
significant  differences  between  males  and  females  exist.
Some studies have not found differences in the prevalence
between  genders  [7,26];  others  have  found  a  greater
prevalence in females [27,28]; while other investigators have
found a greater prevalence in males.
In the literature, most cases of keratoconus are sporadic,
but a proportion (5%–10%) may be familial [6,7]. In our
population, as judged by the family pedigree, 56.4% of cases
were  sporadic,  34.6%  had  autosomal  recessive  mode  of
inheritance, 5.4% were autosomal dominant, and 3.6% of
cases were difficult to determine. So 40% (22 patients) of our
keratoconus cohort were familial and this percentage is higher
than that reported previously in the literature. This high rate
of familial cases, could be attributed to the soaring scale of
consanguinity in this society which reaches up to 60% in some
areas of the Kingdom [29].
In  the  literature,  90%  of  pedigrees  with  familial
keratoconus display an autosomal dominant inheritance with
reduced penetrance [8,30]. Other modes of inheritance have
been  described,  including  autosomal  recessive  mode  in
families with children of consanguineous parents [31,32]. In
our  population,  the  familial  cases  (19  out  of  22)  had  an
autosomal recessive mode of inheritance. This is ideal for
linkage  analysis  to  identify  the  causative  gene(s)  in  our
population by focusing on families with multiple affected
individuals, preferably in two or more generations.
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